Diabetic kidney disease (DKD) is the most frequent complication in patients with type 2 diabetes mellitus (T2DM). It causes a chronic and progressive decline in kidney function, and ultimately patients require renal replacement therapy. To date, an increasing number of clinical studies have been conducted to explore the potential and novel biomarkers, which can advance the diagnosis, estimate the prognosis, and optimize the therapeutic strategies at the early stage of DKD. In the current study, we sought to investigate the association of plasma myoglobin with DKD.

中文翻译：

---

血浆肌红蛋白水平升高与2型糖尿病肾病密切相关

糖尿病肾病 (DKD) 是 2 型糖尿病 (T2DM) 患者最常见的并发症。它会导致肾功能慢性进行性下降，最终患者需要肾脏替代治疗。迄今为止，越来越多的临床研究正在探索潜在的新型生物标志物，以促进 DKD 早期诊断、评估预后并优化治疗策略。在当前的研究中，我们试图探讨血浆肌红蛋白与 DKD 的关联。